MolGraph
CompoundsDocumentationComplianceAbout
MolGraph

Research chemical sourcing and molecular building block RFQ workflows.

MolGraph is operated by Tessorix Inc.

support@molgraph.com

Products are intended for laboratory research use only and are not for human or veterinary use.

Compounds

  • Compound catalog
  • CAS Search

Company

  • About
  • Contact

Documentation

  • Quality Documentation
  • SDS Disclaimer

Compliance

  • Compliance

Legal

  • Terms
  • Privacy

Copyright © 2026 MolGraph. All Rights Reserved.

Home/Compounds/CAS 443913-73-3
Formula C22H24BrFN4O2MW 475.4Research-use catalog entryCOA/SDS by request

Vandetanib

CAS Number: 443913-73-3

Sourcing & RFQ

Submit an RFQ to review pricing, availability, lead time, pack size, purity, COA, and supplier SDS for this catalog entry.

Available options

Available Options

Package
1 g
Purity
99%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
25 g
Purity
99%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
250 mg
Purity
99%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
5 g
Purity
99%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required

Shipping review is required before pricing or stock can be confirmed publicly. Shipping, duties, and documentation fees are confirmed before order acceptance.

Loading RDKit molecule structure...
InChIKey: UHTHHESEBZOYNR-UHFFFAOYSA-NC22H24BrFN4O2 | MW 475.4

Chemical Absolute Identifiers

CAS Number

443913-73-3

PubChem CID

3081361

Molecular Formula

C22H24BrFN4O2

Molecular Weight

475.4 g/mol

Exact Mass

474.10667

InChIKey

UHTHHESEBZOYNR-UHFFFAOYSA-N

IUPAC Name

N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine

SMILES String

COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1

Physical Properties

No physical property values available.

Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.

Catalog Facts

Structural features

Vandetanib (CAS 443913-73-3) is listed in the Pharmaceutical Intermediates portfolio, with molecular formula C22H24BrFN4O2 and molecular weight 475. 40 g/mol.

Sourcing context

Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.

Research use context

Intended for research-stage medicinal chemistry and intermediate synthesis workflows; structure-derived tags include nitrogen-containing heterocycle.

Documentation needs

COA/SDS status, availability, lead time, pack size, and shipment documentation can be confirmed during quotation.

Applications & Classification

Pharmaceutical Intermediate ResearchResearch intermediateCustom synthesis building blockPharmaceutical intermediate researchResearch chemical sourcingCustom synthesis and catalog availability reviewCOA, SDS, pricing, and fulfillment workflow
Biological target reference

ChEMBL reports experimental activity evidence for: Vascular endothelial growth factor receptor 3 (Homo sapiens) — 5 assays; Proto-oncogene tyrosine-protein kinase receptor Ret (Homo sapiens) — 39 assays; Proto-oncogene tyrosine-protein kinase Src (Homo sapiens) — 7 assays; Vascular endothelial growth factor receptor 2 (Homo sapiens) — 58 assays; Receptor-interacting serine/threonine-protein kinase 2 (Homo sapiens) — 4 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.

Vascular endothelial growth factor receptor 3

Homo sapiens · SINGLE PROTEIN · 5 qualifying assays · 5 documents · best pChEMBL 9.96

Experimental evidence source: ChEMBL

Proto-oncogene tyrosine-protein kinase receptor Ret

Homo sapiens · SINGLE PROTEIN · 39 qualifying assays · 20 documents · best pChEMBL 9.89

Experimental evidence source: ChEMBL

Proto-oncogene tyrosine-protein kinase Src

Homo sapiens · SINGLE PROTEIN · 7 qualifying assays · 7 documents · best pChEMBL 9.1

Experimental evidence source: ChEMBL

Vascular endothelial growth factor receptor 2

Homo sapiens · SINGLE PROTEIN · 58 qualifying assays · 43 documents · best pChEMBL 8.4

Experimental evidence source: ChEMBL

Receptor-interacting serine/threonine-protein kinase 2

Homo sapiens · SINGLE PROTEIN · 4 qualifying assays · 4 documents · best pChEMBL 8.34

Experimental evidence source: ChEMBL

Safety & Handling

Safety and handling reference content is available through documentation requests.

For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.

Preliminary Safety Reference

For supplier-issued SDS or COA, submit a documentation request.

Safety Reference / SDS Request

Names & Synonyms / External Identifiers

Chemical Name

Vandetanib

Names & Synonyms

ZactimaCaprelsaN-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amineZD 6474N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methyl-4-piperidinyl)methoxy)-4-quinazolinamine
Show all synonyms
N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[(1-methyl-4-piperidinyl)methoxy]-4-quinazolinamine4-Quninazolinamine, N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methyl-4-piperidinyl)methoxy)-vandetanibumvandetanib (zd6474)C22H24BrFN4O24-(4-Bromo-2-fluoroanilino)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolineVandetanib [INN]N-(4-bromo-2-fluoro-phenyl)-6-methoxy-7-[(1-methyl-4-piperidyl)methoxy]quinazolin-4-amineHSDB 81982ivuVandetanib [USAN:INN:BAN:JAN]Caprelsa (TN)CH 331
External Identifiers
EC NUMBER: 669-841-4DSSTOX SUBSTANCE ID: DTXSID1046681CHEMBL ID: CHEMBL24828CHEBI ID: CHEBI:49960UNII: YO460OQ37KDRUGBANK ID: DB05294KEGG ID: D06407METABOLOMICS WORKBENCH ID: 52532NCI THESAURUS CODE: C2737PHARMGKB ID: PA166118341RXCUI: 1098413WIKIDATA ID: Q7914515ZD-64
Experimental Spectrum References
ATR-IR Spectra — Forensic Spectral ResearchRaman Spectra — Forensic Spectral Research
Literature & Patent References
DOI 10.1016/j.bmc.2023.117561Discovery of pyrazolo[3,4-d]pyrimidines as novel mitogen-activated protein kinase kinase 3 (MKK3) inhibitors.DOI 10.1016/j.bmc.2024.117749Discovery of 9H-pyrimido[4,5-b]indole derivatives as dual RET/TRKA inhibitors.DOI 10.1016/j.bmc.2024.117870FDA-approved small molecule kinase inhibitors for cancer treatment (2001-2015): Medical indication, structural optimization, and binding mode Part I.DOI 10.1016/j.ejmech.2023.115977An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L.DOI 10.1016/j.ejmech.2024.116472Recent advances and future directions on small molecule VEGFR inhibitors in oncological conditions.DOI 10.1016/j.ejmech.2024.116891Discovery of 7-(1-methyl-1H-pyrazol-4-yl)-1,6-naphthyridine derivatives as potent inhibitors of rearranged during transfection (RET) and RET solvent-front mutants for overcoming selpercatinib resistance.DOI 10.1016/j.ejmech.2024.116948Sensitive quantification of fibroblast activation protein and high-throughput screening for inhibition by FDA-approved compounds.DOI 10.1021/acs.jmedchem.3c02319Unraveling the Promise of RET Inhibitors in Precision Cancer Therapy by Targeting RET Mutations.

Documentation & Compliance Facts

Compliance Facts

Shipment review: Required

Documentation available by request

Certificate of Analysis (COA): By request

Supplier Safety Data Sheet (SDS): By request

Purity and pack size confirmation: By request

Availability and lead time review: Confirmed by RFQ

Shipment documentation review: By request

For supplier-issued documentation by request, use the RFQ actions on this page.Review preliminary safety reference

What happens after RFQ

  1. 1We review the CAS identity, quantity, and documentation request.
  2. 2We check sourcing options, supplier availability, COA/SDS, purity, pack size, and lead time.
  3. 3We review destination and shipment documentation needs when applicable.
  4. 4We follow up with a quotation or clarification request.

Text Reference Cues

Show non-linked catalog cues

Non-public related references

tert-Butyl 4-(((4-((4-bromo-2-fluorophenyl)amino)-6-methoxyquinazolin-7-yl)oxy)methyl)piperidine-1-carboxylateCAS 338992-20-4
7-(Benzyloxy)-N-(4-bromo-2-fluorophenyl)-6-methoxyquinazolin-4-amineCAS 768350-54-5
4-[(4-Bromo-2-fluorophenyl)amino]-6-methoxy-7-quinazolinolCAS 196603-96-0
4-Chloro-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolineCAS 264208-72-2
6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]-1H-quinazolin-4-oneCAS 264208-69-7

Non-public references are shown as text only and do not imply equivalence, availability, or shared use.

Catalog navigation

Related Catalog Entries

Other public CAS pages in this catalog. These links support navigation across additional intermediates and do not imply equivalence, availability, or shared use.

CAS 571190-30-2PalbociclibCAS 120685-11-2MidostaurinCAS 62996-74-1StaurosporineCAS 338992-20-4tert-Butyl 4-(((4-((4-bromo-2-fluorophenyl)amino)-6-methoxyquinazolin-7-yl)oxy)methyl)piperidine-1-carboxylateCAS 768350-54-57-(Benzyloxy)-N-(4-bromo-2-fluorophenyl)-6-methoxyquinazolin-4-amineCAS 196603-96-04-[(4-Bromo-2-fluorophenyl)amino]-6-methoxy-7-quinazolinolCAS 264208-72-24-Chloro-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolineCAS 264208-69-76-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]-1H-quinazolin-4-oneCAS 319460-85-0AxitinibCAS 1002310-00-0Tert-butyl 1-(2-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethylcarbamate

RFQ questions for CAS 443913-73-3

What are the key identifiers for Vandetanib (CAS 443913-73-3)?

Vandetanib is identified by CAS 443913-73-3, with molecular formula C22H24BrFN4O2, molecular weight 475.4, InChIKey UHTHHESEBZOYNR-UHFFFAOYSA-N.

Does CAS 443913-73-3 have reported biological target evidence?

ChEMBL contains qualifying experimental assay evidence associated with Vascular endothelial growth factor receptor 3, Proto-oncogene tyrosine-protein kinase receptor Ret, Proto-oncogene tyrosine-protein kinase Src, Vascular endothelial growth factor receptor 2, Receptor-interacting serine/threonine-protein kinase 2. These records do not establish therapeutic efficacy or clinical use.

Can I request a COA for CAS 443913-73-3?

Yes. Submit an RFQ and specify COA requirements. Lot-specific COA depends on supplier confirmation.

Can I request supplier SDS for Vandetanib?

Yes. Supplier SDS can be requested through the RFQ workflow before handling, storage, shipment, or procurement decisions.

Is CAS 443913-73-3 available for quotation?

Availability, pack size, lead time, and pricing are confirmed through RFQ.

Can MolGraph support bulk sourcing or custom synthesis review?

Submit the CAS number, quantity, purity requirement, and destination country for sourcing review.